Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Trends in incidence of oral anticoagulant-related intracerebral hemorrhage and sales of oral anticoagulants in Capital Region of Denmark 2010–2017

Research output: Contribution to journalJournal articleResearchpeer-review

  1. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fourth European stroke science workshop

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Nursing Home Admission and Initiation of Domiciliary Care After Ischemic Stroke – The Importance of Time to Thrombolysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Recurrent Ischemic Stroke – A Systematic Review and Meta-Analysis

    Research output: Contribution to journalReviewpeer-review

  3. Lumbar puncture position influences intracranial pressure

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Renal Impairment and Risk of Acute Stroke: The INTERSTROKE Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Effect of intravenous alteplase on post-stroke depression in the WAKE UP trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction: Non-vitamin K-antagonist oral anticoagulants (NOAC) have become first choice oral anticoagulant (OAC) with decreasing use of vitamin K antagonists (VKA), partly due to lower risk of intracerebral hemorrhage (ICH). Aim: to identify trends in sale of OACs and relate them to trends in OAC-related ICH (OAC-ICH). Patients and methods: Study was based on the population in the Capital Region of Denmark (1.8 million inhabitants). We identified all patients admitted with a non-traumatic OAC-ICH in 2010–2017 and ascertained diagnosis and drug use through medical charts. We used information available in the public domain on sale of defined daily doses (DDD) of OAC in the Capital Region of Denmark. Results: 453 patients with OAC-ICH out of a total of 2877 ICH-events were identified. From 2010 to 2017 sale of NOAC rose from 0.1 to 11.8 DDD/1000 inhabitants/day (p < 0.001); while VKA sale decreased from 7.6 to 5.2 DDD/1000 inhabitants/day (p < 0.001). The total number of ICH events was stable between 2010 and 2017, but the proportion of OAC-ICH events increased from 13% in 2010 to 22% in 2017 (p < 0.001). The proportion of ICH events related to NOAC had a significant increasing trend (p < 0.001), whereas a decreasing trend was observed for VKA (p = 0.04). Discussion: In Denmark, the population on OACs has increased; resulting from increased use of NOACs. Parallel to this development, the proportion of OAC-ICH overall has increased based on an increasing trend in NOAC-related ICH. Conclusion: Our findings document a need for further research on prevention and treatment of this complication.

Original languageEnglish
JournalEuropean Stroke Journal
Volume6
Issue number2
Pages (from-to)143-50
ISSN2396-9873
DOIs
Publication statusPublished - 2021

    Research areas

  • direct oral anticoagulants, hemorrhagic stroke, intracerebral hemorrhage, new oral anticoagulants, Non-vitamin K-antagonist oral anticoagulants, vitamin K-antagonists

ID: 66257347